Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.670
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
2.650
-0.020 (-0.75%)
After-hours: Apr 28, 2026, 7:30 PM EDT
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $154.57 million as of April 28, 2026. Its market cap has increased by 378.55% in one year.
Market Cap
154.57M
Enterprise Value
117.49M
1-Year Change
378.55%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has increased from $154.10M to $154.57M, an increase of 0.31%. That is a compound annual growth rate of 0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 154.60M | 17.75% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 164.63M |
| ProQR Therapeutics | 163.31M |
| AN2 Therapeutics | 156.22M |
| Oramed Pharmaceuticals | 155.72M |
| Molecular Partners AG | 155.64M |
| Humacyte | 155.41M |
| Fate Therapeutics | 154.63M |
| Galectin Therapeutics | 153.38M |